Photo: ralph orlowski/Reuters Germany’s Merck MRK -0.86% KGaA shares dropped after the company slashed its full-year outlook on the back of uncertainty around tariffs and foreign-exchange headwinds.

By Helena Smolak Germany's Merck KGaA slashed its full-year outlook on the back of challenging macroeconomic conditions and foreign-exchange headwinds. The life-sciences and electronics company ...

Merck KGaA Q1 Results Rise; Cuts FY25 Outlook May 15, 2025 — 01:20 am EDT Written by RTTNews.com for RTTNews -> ...

Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...

Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove ...

Merck is undervalued with strong growth, profitability, and credit strength despite CDMO challenges, offering compelling ...

Merck KGaA expects full-year sales to come in between €20.9 billion and €22.4 billion, previously forecast at between €21.5 billion and €22.9 billion.© ralph orlowski/Reuters ...